About SINGLE DOSE THERAPEUTICS, INC
Single Dose Therapeutics is a public benefit corporation focused on developing neuroplastogens to address maladaptive learning, enhance psychological resilience, and support cognitive health in psychiatric and neurodegenerative conditions. The company is advancing drug candidates through preclinical and clinical stages to address critical unmet medical needs.
Development of neuroplastogens for psychiatric and neurodegenerative conditionsPreclinical and clinical drug developmentResearch into neuroadaptive processes and allostasisEvaluation of drug candidates for enhancing neuroplasticity without psychotomimetic effects
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to SINGLE DOSE THERAPEUTICS, INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.